Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: riluzole | Statement: [ALS, hasTreatment, riluzole]

Target entity: riluzole
Context triple: [ALS, hasTreatment, riluzole]

• A. Spinraza
  Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
• B. rivastigmine
  Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
• C. memantine
  Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
• D. Tysabri
  Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
• E. Tecfidera
  Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: riluzole
Triple: [ALS, hasTreatment, riluzole]

Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).

Target entity: riluzole
Target entity description: Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).

• A. Spinraza
  Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
• B. rivastigmine
  Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
• C. memantine
  Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
• D. Tysabri
  Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
• E. Tecfidera
  Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
• F. None of above. chosen

Target predicate: hasTreatment
Context triple: [ALS, hasTreatment, riluzole]

• A. hasSurgery
  Indicates that a surgical procedure is performed on or undergone by an entity.
• B. treatment chosen
  Indicates that one entity is used as a medical or therapeutic intervention to address, manage, or cure a condition affecting another entity.
• C. treats
  Indicates that one entity provides medical care or therapeutic intervention to another entity.
• D. hasInitialDose
  Indicates that an entity has received or is assigned a first or starting dose of a treatment, medication, or substance.
• E. hasHumanUse
  Indicates that something is used, employed, or utilized by humans for a particular purpose or benefit.
• F. None of above.